Need a specific person's email?
Browse NeuExcell Therapeutics's employee directory (about 4 employees) and reveal verified emails free.
NeuExcell Therapeutics's most common email format is FirstLast@neuexcell.com (ex. JohnDoe@neuexcell.com), used for 63% of neuexcell.com addresses. NeuExcell Therapeutics uses 4 email patterns.
| Format | Example | Share of neuexcell.com |
|---|---|---|
| FirstLast@neuexcell.comMost common | JohnDoe@neuexcell.com | |
| FirstLa@neuexcell.com | JohnDo@neuexcell.com | |
| FLast@neuexcell.com | JDoe@neuexcell.com | |
| FirLast@neuexcell.com | JohDoe@neuexcell.com |
Browse NeuExcell Therapeutics's employee directory (about 4 employees) and reveal verified emails free.
Biotechnology ResearchPennsylvania, United States2-10 Employees
NeuExcell Therapeutics is a biotechnology research company focused on gene therapy approaches for neurodegenerative diseases. The organization aims to regenerate neurons in the brain with the goal of improving outcomes for patients facing serious neurological conditions. Its stated disease areas include stroke, Huntington's disease, ALS, and traumatic brain injury. It is based in King of Prussia, Pennsylvania, and described as a small team in the biotech sector. The company positions itself within the biotechnology field as pursuing strategies to restore damaged neural tissue through gene therapy. In May 2026, NeuExcell announced that the first-in-human study of NXL-004 for recurrent malignant glioma will be presented at the ASCO 2026 meeting.
Most common format
FirstLast@neuexcell.com
Example: JohnDoe@neuexcell.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.